Tirzepatide Is the Preferred GLP-1 Agonist for Weight Loss, Meta-Analysis Suggests

The 15 mg dose of tirzepatide was the most efficacious GLP-1 agonist for obesity management in patients without diabetes in a systemic review of data from MEDLINE and Embase databases.

Related Keywords

Canada ,Vancouver ,British Columbia ,Jena Velji Ibrahim ,Eli Lilly ,Prisma Health Greenville Memorial Hospital ,Network Meta ,American College Of Gastroenterology ,University Of South Carolina School Medicine ,South Carolina School ,American College ,Scientific Meeting ,Weight Loss ,Best Option ,Terzepatide ,Semaglutide ,Obese ,Obesity ,Glp 1 ,